Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis

Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID‐19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID‐19 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Çalhan, Turan, Yivli, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908081/
https://www.ncbi.nlm.nih.gov/pubmed/35310310
http://dx.doi.org/10.1002/ccr3.5557
_version_ 1784665797267816448
author Çalhan, Turan
Yivli, Elif
author_facet Çalhan, Turan
Yivli, Elif
author_sort Çalhan, Turan
collection PubMed
description Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID‐19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID‐19 infection, discussing it together with current information.
format Online
Article
Text
id pubmed-8908081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89080812022-03-17 Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis Çalhan, Turan Yivli, Elif Clin Case Rep Case Reports Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID‐19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID‐19 infection, discussing it together with current information. John Wiley and Sons Inc. 2022-03-10 /pmc/articles/PMC8908081/ /pubmed/35310310 http://dx.doi.org/10.1002/ccr3.5557 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Çalhan, Turan
Yivli, Elif
Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title_full Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title_fullStr Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title_full_unstemmed Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title_short Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
title_sort coronavirus disease 2019 (covid‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908081/
https://www.ncbi.nlm.nih.gov/pubmed/35310310
http://dx.doi.org/10.1002/ccr3.5557
work_keys_str_mv AT calhanturan coronavirusdisease2019covid19asapotentialtriggerforbenignrecurrentintrahepaticcholestasis
AT yivlielif coronavirusdisease2019covid19asapotentialtriggerforbenignrecurrentintrahepaticcholestasis

Ejemplares similares